SCIO-469

DRUG5 trials

Sponsors

Scios, Inc.

Conditions

Arthritis, RheumatoidBone Marrow DiseasesBone Marrow NeoplasmsHematologic DiseasesMultiple MyelomaMyelodysplastic SyndromesRheumatoid Arthritis

Phase 2

Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate

CompletedNCT00043732

Scios, Inc.Rheumatoid Arthritis

End: 2003-09-30Updated: 2010-04-27

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

CompletedNCT00087867

Scios, Inc.Multiple Myeloma

Start: 2004-06-30End: 2005-09-30Updated: 2010-10-18

SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate

CompletedNCT00089921

Scios, Inc.Arthritis, Rheumatoid

Start: 2004-07-31End: 2005-10-31Updated: 2010-10-18

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

CompletedNCT00095680

Scios, Inc.Multiple Myeloma

Start: 2004-11-30End: 2006-02-28Updated: 2010-10-22

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

CompletedNCT00113893

Scios, Inc.Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases +1

Start: 2005-05-31End: 2007-12-31Updated: 2013-11-07